Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2025 ,inter alia, to consider and approve Please refer attachment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emmessar Biotech & Nutrition Ltd has informed BSE that a Board of Directors meeting will be held on Thursday, April 24, 2025, in Mumbai. The main agenda item is to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2025. This intimation is being made under Regulation 29(1)(a) of SEBI's Listing Obligations and Disclosure Requirements (LODR), 2015. The filing also reminds stakeholders that the trading window for the company's equity shares remains closed until April 26, 2025, as per SEBI insider trading rules. The company is listed under security code 524768 on BSE.
No immediate impact on shareholders — this is a routine procedural announcement ahead of the FY25 audited results. Investors should watch for the actual results on or after April 24, 2025, which may move the stock depending on performance versus expectations.